Court Documents Show Mirina Held Investment Talks with Big Pharma Players

And while details about the talks were not provided, the filing indicates that Mirina has been negotiating with Merck, Pfizer, Johnson & Johnson, MedImmune, Sanofi-Aventis, AstraZeneca, as well as the investment arms of Eli Lilly and GlaxoSmithKline.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.